Shareholder plans sale of 125,000 BLSH shares

BLSH filed a notice that a shareholder plans to sell up to 125,000 ordinary shares on the NYSE through J.P.

Rhea-AI Filing Summary

BLSH filed a notice that a shareholder plans to sell up to 125,000 ordinary shares on the NYSE through J.P. Morgan Securities LLC. The shares have an aggregate market value of $3,963,750 and are part of 146,183,739 shares outstanding. The planned sale date is on or about February 13, 2026. The shares were originally acquired from the issuer on May 24, 2023 as compensation, meaning they were granted for services rather than purchased for cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for BLSH disclose?

The Form 144 shows a BLSH shareholder intends to sell 125,000 ordinary shares. The proposed sale will be executed on the NYSE through J.P. Morgan Securities LLC, with an indicated aggregate market value of $3,963,750 based on the figures in the notice.

How many BLSH shares are planned for sale under this Form 144?

The filing states that 125,000 ordinary shares of BLSH are planned for sale. These shares are to be sold on the NYSE via J.P. Morgan Securities LLC, with the sale targeted around February 13, 2026, subject to market conditions and Rule 144 requirements.

What is the aggregate market value of the BLSH shares to be sold?

The notice lists an aggregate market value of $3,963,750 for the 125,000 ordinary shares. This figure reflects the market price used in the filing to describe the potential value of the planned sale, not a guaranteed transaction amount.

When were the BLSH shares being sold originally acquired?

According to the filing, the 125,000 BLSH ordinary shares were acquired on May 24, 2023. The nature of the acquisition is described as “Compensation,” indicating the issuer granted these shares as part of a compensation arrangement rather than a cash purchase.

On which exchange will the BLSH shares be sold and through which broker?

The Form 144 states that the BLSH ordinary shares are to be sold on the NYSE. The designated broker for this planned transaction is J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.

How many BLSH shares are outstanding according to this filing?

The filing reports that there are 146,183,739 ordinary shares of BLSH outstanding. This provides context for the planned sale of 125,000 shares, showing the relative size of the potential transaction compared with the total share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 04:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001739817
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bullish
SEC File Number	001-42797
Address of Issuer	10A Building A, 60 Nexus Way George Town CAYMAN ISLANDS KY1-9005
Phone	852-9610-6907
Name of Person for Whose Account the Securities are To Be Sold	David Bonanno
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	125000	3963750	146183739	02/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	05/24/2023	Compensation	Issuer			125000	05/24/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares covered by this filing will be sold today or within three months from the date of this filing.
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for David Bonanno
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)